Cargando…
Prognostic Impact of Sarcopenia and Skeletal Muscle Loss During Neoadjuvant Chemoradiotherapy in Esophageal Cancer
Backgrounds: The relationship between sarcopenia, characterized by loss of muscle mass and strength, and survival outcomes of esophageal cancer is controversial. This study aimed to assess the effect of sarcopenia and skeletal muscle loss on overall survival (OS) and recurrence-free survival (RFS) o...
Autores principales: | Yoon, Han Gyul, Oh, Dongryul, Ahn, Yong Chan, Noh, Jae Myoung, Pyo, Hongryull, Cho, Won Kyung, Song, Yun Mi, Park, Minsu, Hwang, Na Young, Sun, Jong-Mu, Kim, Hong Kwan, Zo, Jae Ill, Shim, Young Mog |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7226603/ https://www.ncbi.nlm.nih.gov/pubmed/32290037 http://dx.doi.org/10.3390/cancers12040925 |
Ejemplares similares
-
Machine learning model for predicting excessive muscle loss during neoadjuvant chemoradiotherapy in oesophageal cancer
por: Yoon, Han Gyul, et al.
Publicado: (2021) -
Feasibility of an Interactive Health Coaching Mobile App to Prevent Malnutrition and Muscle Loss in Esophageal Cancer Patients Receiving Neoadjuvant Concurrent Chemoradiotherapy: Prospective Pilot Study
por: Yang, Kyungmi, et al.
Publicado: (2021) -
Supraclavicular and/or celiac lymph node metastases from thoracic esophageal squamous cell carcinoma did not compromise survival following neoadjuvant chemoradiotherapy and surgery
por: Cho, Won Kyung, et al.
Publicado: (2016) -
Adjuvant therapy in stage IIIA-N2 non-small cell lung cancer after neoadjuvant concurrent chemoradiotherapy followed by surgery
por: Shin, Sumin, et al.
Publicado: (2020) -
Esophageal Cancer: Overcome the Hurdles and Reach for the Cure
por: Kim, Hong Kwan, et al.
Publicado: (2020)